Seastar Medical Holding Corp - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Seastar Medical Holding Corporation (Nasdaq: ICU, ICUCW) on January 20, 2026. The company is incorporated in Delaware and operates as an emerging growth company. The report addresses a specific regulatory event regarding its listing status on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance rather than financial performance.
Material Changes
The primary material event reported is the company regaining compliance with the Nasdaq Listing Rule 5550(a)(2), known as the "Minimum Bid Price Rule." On January 20, 2026, the Nasdaq Office of General Counsel confirmed that the company's common stock now meets the minimum bid price requirement of $1.00 per share.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. No new risks, contingencies, or unusual items were disclosed in this specific report beyond the resolution of the prior non-compliance issue.
Investor Verification Checklist
- Verify the current trading price of ICU to ensure it remains above the $1.00 threshold.
- Confirm the duration of the compliance period required by Nasdaq to maintain listing status.
- Review prior 8-K filings to understand the timeline and cause of the previous non-compliance.
- Check for any concurrent announcements regarding reverse stock splits or other capital structure changes that may have facilitated compliance.